Mobile phone-based interventions for improving contraception use.
Journal
The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747
Informations de publication
Date de publication:
17 07 2023
17 07 2023
Historique:
pmc-release:
17
07
2024
medline:
19
7
2023
pubmed:
17
7
2023
entrez:
17
7
2023
Statut:
epublish
Résumé
Contraception provides significant benefits for women's and children's health, yet many women have an unmet need for contraception. Rapid expansion in the use of mobile phones in recent years has had a dramatic impact on interpersonal communication. Within the health domain text messages and smartphone applications offer means of communication between clients and healthcare providers. This review focuses on interventions delivered by mobile phone and their effect on use of contraception. To evaluate the benefits and harms of mobile phone-based interventions for improving contraception use. We used standard, extensive Cochrane search methods. The latest search date was August 2022. We included randomised controlled trials (RCTs) of mobile phone-based interventions to improve forms of contraception use amongst users or potential users of contraception. We used standard Cochrane methods. Our primary outcomes were 1. uptake of contraception, 2. uptake of a specific method of contraception, 3. adherence to contraception method, 4. safe method switching, 5. discontinuation of contraception and 6. pregnancy or abortion. Our secondary outcomes were 7. road traffic accidents, 8. any physical or psychological effect reported and 9. violence or domestic abuse. Twenty-three RCTs (12,793 participants) from 11 countries met our inclusion criteria. Eleven studies were conducted in high-income resource settings and 12 were in low-income settings. Thirteen studies used unidirectional text messaging-based interventions, six studies used interactive text messaging, four used voice message-based interventions and two used mobile-phone apps to improve contraception use. All studies received funding from non-commercial bodies. Mobile phone-based interventions probably increase contraception use compared to the control (odds ratio (OR) 1.30, 95% confidence interval (CI) 1.06 to 1.60; 16 studies, 8972 participants; moderate-certainty evidence). There may be little or no difference in rates of unintended pregnancy with the use of mobile phone-based interventions compared to control (OR 0.82, 95% CI 0.48 to 1.38; 8 trials, 2947 participants; moderate-certainty evidence). Subgroup analysis assessing unidirectional mobile phone interventions versus interactive mobile phone interventions found evidence of a difference between the subgroups favouring interactive interventions (P = 0.003, I This review demonstrates there is evidence to support the use of mobile phone-based interventions in improving the use of contraception, with moderate-certainty evidence. Interactive mobile phone interventions appear more effective than unidirectional methods. The cost-effectiveness, cost benefits, safety and long-term effects of these interventions remain unknown, as does the evidence of this approach to support contraception use among specific populations. Future research should investigate the effectiveness and safety of mobile phone-based interventions with better quality trials to help establish the effects of interventions delivered by mobile phone on contraception use. This review is limited by the quality of the studies due to flaws in methodology, bias or imprecision of results.
Sections du résumé
BACKGROUND
Contraception provides significant benefits for women's and children's health, yet many women have an unmet need for contraception. Rapid expansion in the use of mobile phones in recent years has had a dramatic impact on interpersonal communication. Within the health domain text messages and smartphone applications offer means of communication between clients and healthcare providers. This review focuses on interventions delivered by mobile phone and their effect on use of contraception.
OBJECTIVES
To evaluate the benefits and harms of mobile phone-based interventions for improving contraception use.
SEARCH METHODS
We used standard, extensive Cochrane search methods. The latest search date was August 2022.
SELECTION CRITERIA
We included randomised controlled trials (RCTs) of mobile phone-based interventions to improve forms of contraception use amongst users or potential users of contraception.
DATA COLLECTION AND ANALYSIS
We used standard Cochrane methods. Our primary outcomes were 1. uptake of contraception, 2. uptake of a specific method of contraception, 3. adherence to contraception method, 4. safe method switching, 5. discontinuation of contraception and 6. pregnancy or abortion. Our secondary outcomes were 7. road traffic accidents, 8. any physical or psychological effect reported and 9. violence or domestic abuse.
MAIN RESULTS
Twenty-three RCTs (12,793 participants) from 11 countries met our inclusion criteria. Eleven studies were conducted in high-income resource settings and 12 were in low-income settings. Thirteen studies used unidirectional text messaging-based interventions, six studies used interactive text messaging, four used voice message-based interventions and two used mobile-phone apps to improve contraception use. All studies received funding from non-commercial bodies. Mobile phone-based interventions probably increase contraception use compared to the control (odds ratio (OR) 1.30, 95% confidence interval (CI) 1.06 to 1.60; 16 studies, 8972 participants; moderate-certainty evidence). There may be little or no difference in rates of unintended pregnancy with the use of mobile phone-based interventions compared to control (OR 0.82, 95% CI 0.48 to 1.38; 8 trials, 2947 participants; moderate-certainty evidence). Subgroup analysis assessing unidirectional mobile phone interventions versus interactive mobile phone interventions found evidence of a difference between the subgroups favouring interactive interventions (P = 0.003, I
AUTHORS' CONCLUSIONS
This review demonstrates there is evidence to support the use of mobile phone-based interventions in improving the use of contraception, with moderate-certainty evidence. Interactive mobile phone interventions appear more effective than unidirectional methods. The cost-effectiveness, cost benefits, safety and long-term effects of these interventions remain unknown, as does the evidence of this approach to support contraception use among specific populations. Future research should investigate the effectiveness and safety of mobile phone-based interventions with better quality trials to help establish the effects of interventions delivered by mobile phone on contraception use. This review is limited by the quality of the studies due to flaws in methodology, bias or imprecision of results.
Identifiants
pubmed: 37458240
doi: 10.1002/14651858.CD011159.pub3
pmc: PMC10363274
doi:
Types de publication
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
CD011159Commentaires et corrections
Type : UpdateOf
Informations de copyright
Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Références
PLoS Med. 2013;10(1):e1001362
pubmed: 23349621
Contraception. 2018 Oct;98(4):281-287
pubmed: 30006030
JMIR Mhealth Uhealth. 2014 Feb 14;2(1):e5
pubmed: 25098569
JMIR Form Res. 2017 Oct 27;1(1):e4
pubmed: 30684398
Pan Afr Med J. 2015 Jun 22;21:138
pubmed: 26327975
Contraception. 2017 Jan;95(1):90-97
pubmed: 27421767
Lancet Glob Health. 2020 Dec;8(12):e1534-e1545
pubmed: 33220217
Reprod Health. 2018 Mar 26;15(1):52
pubmed: 29580246
Contraception. 2018 Mar;97(3):198-204
pubmed: 29246818
J Fam Plann Reprod Health Care. 2017 Jan;43(1):79-80
pubmed: 27888182
J Urban Health. 2015 Jun;92(3):502-12
pubmed: 25840552
Glob Health Sci Pract. 2016 Jun 27;4(2):300-10
pubmed: 27353622
Contraception. 2012 Dec;86(6):716-24
pubmed: 22840278
Eur J Contracept Reprod Health Care. 2020 Aug;25(4):264-268
pubmed: 32436800
Cochrane Database Syst Rev. 2020 Jul 14;8:CD013680
pubmed: 32779730
AIDS Behav. 2016 Sep;20(9):2110-8
pubmed: 26995678
BMC Public Health. 2019 Jul 9;19(1):915
pubmed: 31288772
JMIR Res Protoc. 2015 Jan 23;4(1):e11
pubmed: 25650838
Reprod Health. 2015 Aug 07;12:67
pubmed: 26248769
JMIR Mhealth Uhealth. 2019 Oct 16;7(10):e14404
pubmed: 31621641
J Adolesc Health. 2013 Sep;53(3):387-93
pubmed: 23707402
J Med Assoc Thai. 2012 Feb;95(2):249-56
pubmed: 22435256
Telemed J E Health. 2015 Feb;21(2):81-5
pubmed: 25474190
Am J Public Health. 2016 Sep;106(S1):S117-S124
pubmed: 27689478
Cochrane Database Syst Rev. 2019 Oct 14;10:CD013447
pubmed: 31608981
JMIR Res Protoc. 2016 Jun 17;5(2):e125
pubmed: 27315764
J Med Internet Res. 2020 Jun 22;22(6):e14073
pubmed: 32568092
Sex Transm Infect. 2021 Mar;97(2):141-146
pubmed: 31628248
PLoS One. 2018 Sep 21;13(9):e0204091
pubmed: 30240417
Lancet. 2018 Jun 30;391(10140):2642-2692
pubmed: 29753597
J Adolesc Health. 2017 Dec;61(6):786-790
pubmed: 29056437
AIDS Patient Care STDS. 2019 Dec;33(12):528-537
pubmed: 31750731
Trials. 2019 Apr 23;20(1):228
pubmed: 31014358
Lancet. 2000 Nov 25;356(9244):1837-40
pubmed: 11117928
BMJ Open. 2017 Nov 03;7(11):e017604
pubmed: 29101138
Obstet Gynecol. 2012 Jan;119(1):14-20
pubmed: 22143257
Trials. 2013 Dec 12;14:427
pubmed: 24330763
JMIR Mhealth Uhealth. 2018 Jan 17;6(1):e23
pubmed: 29343463
J Med Internet Res. 2018 Jul 31;20(7):e10756
pubmed: 30064968
Contracept Reprod Med. 2020 Oct 31;5(1):31
pubmed: 33292724
PLoS One. 2012;7(12):e46909
pubmed: 23236345
Glob Health Sci Pract. 2019 Dec 23;7(4):507-514
pubmed: 31874936
Am J Public Health. 2017 Feb;107(2):298-305
pubmed: 27997236
J Womens Health (Larchmt). 2008 May;17(4):579-84
pubmed: 18447762
BMJ. 2016 Feb 03;352:i667
pubmed: 26842821
Appl Psychol Health Well Being. 2018 Nov;10(3):391-413
pubmed: 30198101
J Womens Health (Larchmt). 2010 Dec;19(12):2203-10
pubmed: 21034277
Cochrane Database Syst Rev. 2012 Mar 14;(3):CD009756
pubmed: 22419345
Perspect Sex Reprod Health. 2010 Dec;42(4):251-7
pubmed: 21126301
Contraception. 2013 Feb;87(2):251-6
pubmed: 22935322
Trials. 2018 Apr 19;19(1):235
pubmed: 29673381
Bull World Health Organ. 2015 Dec 1;93(12):842-50A
pubmed: 26668436
J Med Internet Res. 2017 May 17;19(5):e172
pubmed: 28526671
Matern Child Health J. 2011 Dec;15 Suppl 1:S42-53
pubmed: 21809218
Mhealth. 2017 Sep 14;3:39
pubmed: 29184891
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD006611
pubmed: 19821377
BMC Public Health. 2017 Dec 20;17(1):969
pubmed: 29262823
BMJ Open. 2015 Feb 16;5(2):e007552
pubmed: 25687900
BMC Public Health. 2018 Feb 5;18(1):216
pubmed: 29402241
J Epidemiol Community Health. 2012 Jan;66(1):69-74
pubmed: 21415232
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011
pubmed: 18425859
Glob Health Sci Pract. 2019 Jun 27;7(2):273-288
pubmed: 31249023
Reprod Health. 2018 Jul 11;15(1):126
pubmed: 29996854
Cochrane Database Syst Rev. 2015 Jun 26;(6):CD011159
pubmed: 26115146
Contraception. 2014 Sep;90(3):226-33
pubmed: 24850188
JMIR Mhealth Uhealth. 2019 Aug 09;7(8):e12672
pubmed: 31400103
Lancet. 2013 May 18;381(9879):1756-62
pubmed: 23683642
Health Educ Behav. 2019 Feb;46(1):89-96
pubmed: 29896969
Trop Med Int Health. 2020 Oct;25(10):1182-1197
pubmed: 33463875
Health Educ Res. 2011 Oct;26(5):782-94
pubmed: 21447750
Lancet. 2012 Jul 14;380(9837):149-56
pubmed: 22784533
J Med Internet Res. 2019 Oct 9;21(10):e13263
pubmed: 31593543
Comput Inform Nurs. 2017 Nov;35(11):549-553
pubmed: 29112536
BMJ Open. 2016 Dec 23;6(12):e013045
pubmed: 28011811
Stud Fam Plann. 2014 Jun;45(2):105-22
pubmed: 24931071
Contraception. 2009 Aug;80(2):108-12
pubmed: 19631784
PLoS One. 2019 Jun 6;14(6):e0217485
pubmed: 31170176
J Med Internet Res. 2022 Jan 4;24(1):e27696
pubmed: 34982716
JMIR Mhealth Uhealth. 2019 Mar 14;7(3):e11163
pubmed: 30869649
Mhealth. 2017 May 22;3:20
pubmed: 28607906
Health Psychol. 2008 May;27(3):379-87
pubmed: 18624603
BMJ Sex Reprod Health. 2021 Jul;47(3):173-178
pubmed: 32938708
Contraception. 2014 Jul;90(1):29-35
pubmed: 24815098
Syst Rev. 2019 Jan 8;8(1):12
pubmed: 30621784
Health Technol Assess. 2016 Jul;20(57):1-82
pubmed: 27483185
Int J Epidemiol. 1992 Oct;21(5):837-41
pubmed: 1468842
Glob Health Sci Pract. 2019 Sep 26;7(3):386-403
pubmed: 31558596
Pediatrics. 2021 Mar;147(3):
pubmed: 33568491
Int J Gynaecol Obstet. 2016 Jul;134(1):93-8
pubmed: 27126905
Open AIDS J. 2017 Nov 21;11:119-132
pubmed: 29290888
Reprod Health. 2018 Feb 13;15(1):28
pubmed: 29433506
Am J Public Health. 2019 Jun;109(6):934-941
pubmed: 31067089
BMC Pregnancy Childbirth. 2019 Aug 8;19(1):283
pubmed: 31395034
Reprod Health. 2014 Jan 02;11(1):1
pubmed: 24383405
Obstet Gynecol. 2010 Sep;116(3):633-640
pubmed: 20733446
Digit Cult Educ. 2014;6(3):164-182
pubmed: 25593616
Glob Public Health. 2017 Oct;12(10):1297-1314
pubmed: 27108891
J Med Internet Res. 2014 May 30;16(5):e143
pubmed: 24878521
Int J Equity Health. 2013 Oct 16;12:85
pubmed: 24131553
Contraception. 2013 Apr;87(4):449-54
pubmed: 23062523
Acad Pediatr. 2020 May - Jun;20(4):475-484
pubmed: 31560971
Am J Obstet Gynecol. 2015 Jun;212(6):774.e1-7
pubmed: 25582097
Stud Health Technol Inform. 2009;146:154-9
pubmed: 19592826
BMJ. 2014 Oct 24;349:g5978
pubmed: 25742320
J Adolesc Health. 2020 Feb;66(2):224-232
pubmed: 31690536
JMIR Mhealth Uhealth. 2020 Feb 25;8(2):e16276
pubmed: 32130166
J Health Commun. 2018;23(6):542-549
pubmed: 29902122
JMIR Res Protoc. 2020 Aug 7;9(8):e18060
pubmed: 32763885
Womens Health Issues. 2017 Jul - Aug;27(4):420-425
pubmed: 28284586
BMC Public Health. 2018 May 2;18(1):576
pubmed: 29716571
J Pediatr Nurs. 2018 Nov - Dec;43:134-135
pubmed: 30213502
Eur J Contracept Reprod Health Care. 2017 Oct;22(5):396-397
pubmed: 28849952
J Womens Health (Larchmt). 2014 Jul;23(7):596-601
pubmed: 24571282
J Telemed Telecare. 2011;17(3):150-3
pubmed: 21270049
Syst Rev. 2019 May 18;8(1):117
pubmed: 31103044
BMJ Open. 2019 Oct 28;9(10):e029872
pubmed: 31662364
JMIR Hum Factors. 2017 Oct 10;4(4):e26
pubmed: 29017990
BMC Public Health. 2016 Aug 12;16(1):778
pubmed: 27514851
Cochrane Database Syst Rev. 2012 Jul 11;(7):CD007458
pubmed: 22786507
BJOG. 2018 Nov;125(12):1620-1629
pubmed: 29924912